Immuneering (IMRX) Operating Leases (2020 - 2026)
Immuneering (IMRX) posted quarterly Operating Leases of $3.3 million for Q1 2026, down 18.75% year-over-year from $4.1 million in Q1 2025, and down 3.21% quarter-over-quarter from $3.4 million in Q4 2025.
Immuneering (IMRX) Operating Leases (2020 - 2026) Analysis & Trends
Immuneering's Operating Leases history runs 7 years deep, the most recent figure standing at $3.3 million for Q1 2026.
- In Q1 2026, Operating Leases fell 18.75% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (down 18.75% YoY), while the FY2025 annual figure was $3.4 million, down 10.38% from the prior year.
- Operating Leases for Q1 2026 stood at $3.3 million, down from $3.4 million in the prior quarter.
- The five-year high for Operating Leases was $4.7 million in Q1 2023, with the low at $3.3 million in Q1 2026.
- The 5-year median for Operating Leases is $4.2 million (2023), against an average of $4.2 million.
- The sharpest annual moves came in 2022 and 2026: Operating Leases soared 842.53% in 2022, then fell 18.75% in 2026.
- Immuneering's Operating Leases stood at $4.5 million in 2022, then fell by 6.72% to $4.2 million in 2023, then dropped by 8.13% to $3.8 million in 2024, then declined by 10.38% to $3.4 million in 2025, then dropped by 3.21% to $3.3 million in 2026.
- Business Quant data shows IMRX's Operating Leases at $3.3 million in Q1 2026, $3.4 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immuneering | 327.37 Mn | 327.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.63 Mn |
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 3.43 Mn |
| Sep 30, 2025 | 3.92 Mn |
| Jun 30, 2025 | 3.63 Mn |
| Mar 31, 2025 | 4.08 Mn |
| Dec 31, 2024 | 3.82 Mn |
| Sep 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Dec 31, 2023 | 4.16 Mn |
| Sep 30, 2023 | 4.54 Mn |
| Jun 30, 2023 | 4.31 Mn |
| Mar 31, 2023 | 4.74 Mn |
| Dec 31, 2022 | 4.46 Mn |
| Sep 30, 2022 | 4.54 Mn |
| Jun 30, 2022 | 4.64 Mn |
| Mar 31, 2022 | 4.71 Mn |
| Dec 31, 2021 | 5.09 Mn |
| Sep 30, 2021 | 481,965.00 |